NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT02922764 2025-03-26A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerInspirna, Inc.Phase 1 Completed146 enrolled
NCT00315861 2009-01-23Topotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesSCRI Development Innovations, LLCPhase 1 Completed15 enrolled